about
Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2Metabolic, autophagic, and mitophagic activities in cancer initiation and progressionTwisted tango: brain tumor neurovascular interactionsGlioma stem cells promote radioresistance by preferential activation of the DNA damage responseBrain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.c-Myc is required for maintenance of glioma cancer stem cells.Targeting A20 decreases glioma stem cell survival and tumor growth.Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy.The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growthIntegrin alpha 6 regulates glioblastoma stem cells.Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell linesA functional screen identifies miRs that induce radioresistance in glioblastomas.Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneityA new mitochondrial pool of cyclin E, regulated by Drp1, is linked to cell-density-dependent cell proliferation.Laminin alpha 2 enables glioblastoma stem cell growthMethod for Efficient Transduction of Cancer Stem Cells.Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways.Brain cancer stem cells display preferential sensitivity to Akt inhibition.NDRG4 is required for cell cycle progression and survival in glioblastoma cells.Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.Aptamer identification of brain tumor-initiating cells.Glioma stem cell maintenance: the role of the microenvironment.SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.NOS Expression and NO Function in Glioma and Implications for Patient Therapies.Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity.Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.334 A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas.The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion.A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.Molecular targeting of neural cancer stem cells: TTAGGG, you're it!The quest for self-identity: not all cancer stem cells are the same.
P50
Q24628857-FF61A742-0EDC-4B5D-9ACA-C594101665C4Q26745503-07F886CB-81D4-408C-9D7F-9D7CF542EB41Q26849613-B65C759F-B812-4FC9-8899-EEBD0CC2CC12Q27860541-4C3133B1-1625-4F9A-AAF7-38FA9FF2B431Q30572367-81A929A8-5B50-4B12-ABE0-20D9A785FF60Q33385645-908E5CD8-5355-4935-951F-701910A5878DQ33534629-629B91D8-4D14-4951-A8D5-D270E4A17E8AQ33671783-DDD0C7E0-6FB1-4691-9B42-58B8BFCEC21BQ33674720-A16A2E8D-CFA4-405D-AF97-63316096B242Q33674790-ED673533-5C66-4BC0-A136-D253FFB3B350Q33908472-D8554097-F5BE-4772-850D-40E0B1ED29B7Q34006181-1B57ECEB-5BB6-488C-943B-28D4400EB909Q34035852-DE76D1DD-5B57-4D9B-9ACD-50C1B76B8B68Q34544632-271C74A2-440E-4F72-BC54-E4A65A16AA11Q35285532-2E8372DA-66D3-409B-83C3-E5E8D854C18FQ35788935-8EC12CC8-D471-4AEB-8633-AA69D6C0A99AQ36020891-F8C20EBE-1ABD-4CA0-B6C8-CA84D5371695Q36462337-FFC0827A-9C0B-434A-8F0C-B2AEF6D84686Q36737141-A5911AA1-2048-4B4E-BF61-BBCD0E77172AQ37186766-08A4E86E-C46C-42B5-A80F-764B50B17EC5Q37221453-43AEE458-5947-4E95-BF8E-A1F80290FF6AQ37285008-3F57D9DA-A015-4BA3-9274-A5925A1AA023Q37335643-83879BB2-EE89-4255-9E1C-C44BC13244BCQ37375751-90148D83-40EC-4284-A718-8AC090689078Q37397814-FD80328D-1DCD-434B-8E73-D8D8B76E1CECQ37507256-08C95D44-493A-4D19-B0E4-B5B5EE93D652Q37601425-0FBC8B84-63FE-41BC-A0AC-C21F8B59D2CAQ37914244-3FF8071F-E8FE-4137-A266-8110BEF790DFQ38339796-90FE1C7F-3FC4-4AC1-A3D9-BCEBB913A351Q38842322-C8702616-E9CE-4D3A-B592-ED36E6491493Q39266434-EA52098A-69E9-49BC-ABFB-E8ED4A41ED8BQ39560754-51763BD7-5CA2-498F-ABBB-69AF5D77B2B5Q39614608-56AF3BE2-204E-47A1-8D36-3C2638628318Q40085993-3DE8B4C3-5461-4F4C-9F0A-96A38D4D892AQ40183817-21E35C2D-C771-4FC2-BE68-AFA5F8E0DCE5Q40236389-C7ACAD37-0D3E-42E2-8DF9-157D7B7F8246Q40339658-24135607-2270-4CD2-A1FD-FEA808E6B79EQ40842765-3234B0FB-30C9-4FC3-AF1A-D4A53C330CB0Q41821769-AE5D4456-0D87-401A-B4FC-14BD2F90E62EQ42224382-BCBC24BF-A3E1-420D-8337-FF123072B1B7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Anita B Hjelmeland
@en
Anita B Hjelmeland
@nl
type
label
Anita B Hjelmeland
@en
Anita B Hjelmeland
@nl
prefLabel
Anita B Hjelmeland
@en
Anita B Hjelmeland
@nl
P31
P496
0000-0003-2200-3248